Related Experiment Video
Updated: Jan 13, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
The Nrf2-GPX4 Pathway Provides Protection Against Rheumatoid Arthritis via Inhibition of Macrophage
Bingxue Liang1, Long Li1, Xiang Ma1
1College of Acupuncture and Tuina, Chongqing University of Chinese Medicine, Chongqing, China.
Abstract:
Abnormal activation and proliferation of rheumatoid arthritis synovial fibroblasts (RASFs) play an important role in rheumatoid arthritis (RA), the mechanism of which remains elusive. The purpose of our study is to comprehensively explore the mechanism of the Nrf2-GPX4 pathway-mediated abnormal RASF activation in RA. Here, we found that Nrf2 and GPX4 protein expression levels were downregulated in the synovial tissues of complete Freund's adjuvant (CFA)-induced adjuvant-induced arthritis (AIA) rats compared with those in control rats. However, Nrf2-GPX4 activation by the Nrf2 activator CDDO-EA could abrogate the CFA-induced macrophage ferroptosis and inflammatory response, as suggested by decreased levels of 5-HT, TNF-α, IL-6, MDA, Fe2+, and lipid peroxidation, yet increased levels of SOD and GSH. As such, Nrf2-GPX4 relieved CFA-induced arthritis in rats. We further found that Nrf2-GPX4 activation arrested macrophage ferroptosis and M1 polarization, and restrained RASF proliferation in vitro. More strikingly, these effects of Nrf2-GPX4 could be partially abolished by the ferroptosis inducer RSL-3. In conclusion, our study provides the first evidence that activated Nrf2-GPX4 can retard RA by suppressing macrophage ferroptosis, M1 polarization, and RASF proliferation. These results provide a new perspective for understanding RA pathogenesis and finding new therapeutic targets.
Insights
Activating the Nrf2-GPX4 pathway can reduce rheumatoid arthritis (RA) by preventing macrophage ferroptosis and M1 polarization, thereby inhibiting synovial fibroblast proliferation. This discovery offers new therapeutic targets for RA.
Area of Science:
- Immunology
- Molecular Biology
- Pathogenesis of Rheumatoid Arthritis
Background:
- Rheumatoid arthritis (RA) involves abnormal activation and proliferation of synovial fibroblasts (RASFs).
- The precise mechanisms driving RASF activation in RA remain unclear.
- Understanding these mechanisms is crucial for developing effective RA treatments.
Purpose of the Study:
- To investigate the role of the Nrf2-GPX4 pathway in regulating RASF activation in RA.
- To explore the therapeutic potential of activating the Nrf2-GPX4 pathway in RA models.
Main Methods:
- Utilized a complete Freund's adjuvant (CFA)-induced adjuvant-induced arthritis (AIA) rat model.
- Administered Nrf2 activator CDDO-EA to assess its effects on macrophage ferroptosis and inflammation.
- Evaluated the impact of Nrf2-GPX4 activation on RASF proliferation in vitro.
- Used ferroptosis inducer RSL-3 to validate the role of ferroptosis.
Main Results:
- Nrf2 and GPX4 protein levels were reduced in AIA rat synovial tissues.
- CDDO-EA treatment decreased inflammatory markers (TNF-α, IL-6) and ferroptosis indicators (MDA, Fe2+) while increasing antioxidants (SOD, GSH).
- Nrf2-GPX4 activation suppressed macrophage ferroptosis and M1 polarization, and inhibited RASF proliferation in vitro.
- The protective effects of Nrf2-GPX4 were partially reversed by RSL-3.
Conclusions:
- The Nrf2-GPX4 pathway plays a critical role in regulating macrophage ferroptosis and M1 polarization.
- Activated Nrf2-GPX4 effectively suppresses RASF proliferation, offering a potential therapeutic strategy for RA.
- This study highlights the Nrf2-GPX4 pathway as a novel target for RA treatment.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
